AIMS/HYPOTHESIS: Human islet cells survive poorly in culture and are overgrown by non-endocrine cells. The aims of this study were to sort human beta cells and to develop approaches for their improved survival in culture. METHODS: Human islets were infected with recombinant adenovirus expressing green fluorescent protein (GFP) under the control of the rat insulin promoter such that only beta cells expressed GFP. GFP-positive beta cells were sorted by flow cytometry, and expression of select integrins evaluated by RT-PCR. Beta cells were cultured on different extracellular matrices for up to 15 days. Apoptosis was measured by annexin V binding and ELISA. Insulin secretion was measured by ELISA. RESULTS: Sorted beta cells survived less well in culture than unsorted islet cells. This did not appear to be due to adenoviral infection and/or GFP expression. Purified beta cells expressed the integrins alpha 3, alpha 5, alpha 6, alpha V, beta1, but not beta 4. Of the various matrices tested, sorted beta cells attached and spread best on a lawn of lysed human bladder carcinoma cells (5637 cells). However, survival remained poor. Cell death was decreased but not prevented by continued presence of 10 mmol/l nicotinamide and apoptosis decreased by 24 h incubation with 20 micromol/l Z-VAD. Insulin secretion was maintained over 6 days following treatment with both agents. CONCLUSIONS/ INTERPRETATION: Purification of human beta cells induces marked apoptosis limiting their function and survival in vitro. This was improved by matching the extracellular matrix to the specific expression of integrins and by addition of nicotinamide and Z-VAD.
AIMS/HYPOTHESIS: Human islet cells survive poorly in culture and are overgrown by non-endocrine cells. The aims of this study were to sort human beta cells and to develop approaches for their improved survival in culture. METHODS:Human islets were infected with recombinant adenovirus expressing green fluorescent protein (GFP) under the control of the ratinsulin promoter such that only beta cells expressed GFP. GFP-positive beta cells were sorted by flow cytometry, and expression of select integrins evaluated by RT-PCR. Beta cells were cultured on different extracellular matrices for up to 15 days. Apoptosis was measured by annexin V binding and ELISA. Insulin secretion was measured by ELISA. RESULTS: Sorted beta cells survived less well in culture than unsorted islet cells. This did not appear to be due to adenoviral infection and/or GFP expression. Purified beta cells expressed the integrins alpha 3, alpha 5, alpha 6, alpha V, beta1, but not beta 4. Of the various matrices tested, sorted beta cells attached and spread best on a lawn of lysed humanbladder carcinoma cells (5637 cells). However, survival remained poor. Cell death was decreased but not prevented by continued presence of 10 mmol/l nicotinamide and apoptosis decreased by 24 h incubation with 20 micromol/l Z-VAD. Insulin secretion was maintained over 6 days following treatment with both agents. CONCLUSIONS/ INTERPRETATION: Purification of human beta cells induces marked apoptosis limiting their function and survival in vitro. This was improved by matching the extracellular matrix to the specific expression of integrins and by addition of nicotinamide and Z-VAD.
Authors: T Linn; J Schmitz; I Hauck-Schmalenberger; Y Lai; R G Bretzel; H Brandhorst; D Brandhorst Journal: Clin Exp Immunol Date: 2006-05 Impact factor: 4.330
Authors: R Aikin; S Hanley; D Maysinger; M Lipsett; M Castellarin; S Paraskevas; L Rosenberg Journal: Diabetologia Date: 2006-10-20 Impact factor: 10.122
Authors: Woon Teck Yap; David M Salvay; Michael A Silliman; Xiaomin Zhang; Zachary G Bannon; Dixon B Kaufman; William L Lowe; Lonnie D Shea Journal: Tissue Eng Part A Date: 2013-06-27 Impact factor: 3.845
Authors: So Young Chun; David L Mack; Emily Moorefield; Se Heang Oh; Tae Gyun Kwon; Mark J Pettenati; James J Yoo; Paolo De Coppi; Anthony Atala; Shay Soker Journal: J Tissue Eng Regen Med Date: 2012-11-13 Impact factor: 3.963
Authors: Domenico Bosco; Paolo Meda; Philippe Morel; David Matthey-Doret; Dorothée Caille; Christian Toso; Leo H Bühler; Thierry Berney Journal: Diabetologia Date: 2005-07-07 Impact factor: 10.122